160 Federal Register / Vol. 83, No. 1 / Tuesday, January 2, 2018 / Notices 

the availability of information regarding 

this action. You may obtain publiclyavailable information related to this 

action by any of the following methods: 

• Federal rulemaking website: Go to 

http://www.regulations.gov and search 

for Docket ID NRC–2017–0215. 

• NRC’s Agencywide Documents 

Access and Management System 

(ADAMS): You may obtain publiclyavailable documents online in the 

ADAMS Public Documents collection at 

http://www.nrc.gov/reading-rm/ 

adams.html. To begin the search, select 

‘‘ADAMS Public Documents’’ and then 

select ‘‘Begin Web-based ADAMS 

Search.’’ For problems with ADAMS, 

please contact the NRC’s Public 

Document Room (PDR) reference staff at 

1–800–397–4209, 301–415–4737, or by 

email to pdr.resource@nrc.gov. The draft 

Y–90 Microsphere Brachytherapy 

Sources and Devices Licensing 

Guidance, Revision 10, is available in 

ADAMS under Accession No. 

ML17107A375. 

• NRC’s PDR: You may examine and 

purchase copies of public documents at 

the NRC’s PDR, Room O1–F21, One 

White Flint North, 11555 Rockville 

Pike, Rockville, Maryland 20852. 

The draft Y–90 Microsphere 

Brachytherapy Sources and Devices 

Licensing Guidance, Revision 10, is also 

available on the NRC’s public website 

on the ‘‘Medical Uses Licensee Toolkit’’ 

page at https://www.nrc.gov/materials/ 

miau/med-use-toolkit.html. 

B. Submitting Comments 

Please include Docket ID NRC–2017– 

0215 in your comment submission. 

The NRC cautions you not to include 

identifying or contact information that 

you do not want to be publicly 

disclosed in your comment submission. 

The NRC will post all comment 

submissions at http://

www.regulations.gov as well as enter the 

comment submissions into ADAMS. 

The NRC does not routinely edit 

submissions to remove identifying or 

contact information. 

If you are requesting or aggregating 

comments from other persons for 

submission to the NRC, then you should 

inform those persons not to include 

identifying or contact information that 

they do not want to be publicly 

disclosed in their comment submission. 

Your request should state that the NRC 

does not routinely edit comment 

submissions to remove such information 

before making the comment 

submissions available to the public or 

entering the comment submission into 

ADAMS. 

II. Discussion 

On November 7, 2017, the NRC 

solicited comments on its draft licensing 

guidance entitled ‘‘Yttrium-90 (Y–90) 

Microsphere Brachytherapy Sources and 

Devices TheraSphere® and SIRSpheres® Licensing Guidance.’’ This 

draft would be revision 10 to this 

licensing guidance. The licensing 

guidance for Y–90 microsphere 

brachytherapy was initially published 

in October 2002 and subsequently 

revised in 2004, 2007, 2008, 2011, 2012, 

and 2016. Following years of using the 

current licensing guidance, the NRC 

staff, stakeholders, and the Advisory 

Committee on the Medical Uses of 

Isotopes identified numerous issues that 

need to be addressed. A working group 

composed of Agreement State 

representatives and NRC staff was 

formed to address identified issues. This 

draft licensing guidance for Y–90 

microsphere brachytherapy has been 

revised to update criteria for training 

and experience, medical event 

reporting, inventory requirement 

specifications, and waste disposal 

issues. The draft guidance provides new 

information regarding cremation and 

autopsy. The public comment period 

was originally scheduled to close on 

January 8, 2018. The NRC has decided 

to extend the public comment period on 

this document until February 8, 2018, to 

allow more time for members of the 

public to submit their comments. 

Dated at Rockville, Maryland, this 27th day 

of December 2017. 

For the Nuclear Regulatory Commission. 

Kevin Williams, 

Deputy Director, Division of Material Safety, 

State, Tribal and Rulemaking Programs, 

Office of Nuclear Material Safety and 

Safeguards. 

[FR Doc. 2017–28271 Filed 12–29–17; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[NRC–2017–0001] 

Sunshine Act Meeting Notice 

DATE: Weeks of January 1, 8, 15, 22, 29, 

February 5, 2018. 

PLACE: Commissioners’ Conference 

Room, 11555 Rockville Pike, Rockville, 

Maryland. 

STATUS: Public and Closed. 

Week of January 1, 2018 

There are no meetings scheduled for 

the week of January 1, 2018. 

Week of January 8, 2018—Tentative 

There are no meetings scheduled for 

the week of January 8, 2018. 

Week of January 15, 2018—Tentative 

Thursday, January 18, 2018 

9:00 a.m. Strategic Programmatic 

Overview of the Decommissioning 

and Low-Level Waste and Spent 

Fuel Storage and Transportation 

Business Lines (Public Meeting) 

(Contact: Damaris Marcano: 301– 

415–7328) 

This meeting will be webcast live at 

the Web address—http://www.nrc.gov/. 

Week of January 22, 2018—Tentative 

Tuesday, January 23, 2018 

9:00 a.m. Hearing on Construction 

Permit for Northwest Medical 

Isotopes Production Facility: 

Section 189a of the Atomic Energy 

Act Proceeding (Public Meeting) 

(Contact: Michael Balazik: 301– 

415–2856) 

This meeting will be webcast live at 

the Web address—http://www.nrc.gov/. 

Thursday, January 25, 2018 

10:00 a.m. Strategic Programmatic 

Overview of the New Reactors 

Business Line (Public Meeting) 

(Contact: Donna Williams: 301– 

415–1322) 

This meeting will be webcast live at 

the Web address—http://www.nrc.gov/. 

Week of January 29, 2018—Tentative 

There are no meetings scheduled for 

the week of January 29, 2018. 

Week of February 5, 2018—Tentative 

Thursday, February 8, 2018 

9:00 a.m. Discussion of Potential 

Changes to the 10 CFR 2.206 

Enforcement Petition Process 

(Public Meeting) (Contact: Doug 

Broaddus: 301–415–8124) 

This meeting will be webcast live at 

the Web address—http://www.nrc.gov/. 

* * * * * 

The schedule for Commission 

meetings is subject to change on short 

notice. For more information or to verify 

the status of meetings, contact Denise 

McGovern at 301–415–0681 or via email 

at Denise.McGovern@nrc.gov. 

* * * * * 

The NRC Commission Meeting 

Schedule can be found on the internet 

at: http://www.nrc.gov/public-involve/ 

public-meetings/schedule.html. 

* * * * * 

The NRC provides reasonable 

accommodation to individuals with 

disabilities where appropriate. If you 

need a reasonable accommodation to 


daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 1 / Tuesday, January 2, 2018 / Notices 161 

participate in these public meetings, or 

need this meeting notice or the 

transcript or other information from the 

public meetings in another format (e.g., 

braille, large print), please notify 

Kimberly Meyer, NRC Disability 

Program Manager, at 301–287–0739, by 

videophone at 240–428–3217, or by 

email at Kimberly.Meyer-Chambers@

nrc.gov. Determinations on requests for 

reasonable accommodation will be 

made on a case-by-case basis. 

* * * * * 

Members of the public may request to 

receive this information electronically. 

If you would like to be added to the 

distribution, please contact the Nuclear 

Regulatory Commission, Office of the 

Secretary, Washington, DC 20555 (301– 

415–1969), or email Patricia.Jimenez@

nrc.gov or Jennifer.BorgesRoman@

nrc.gov. 

December 28, 2017. 

Denise L. McGovern, 

Policy Coordinator, Office of the Secretary. 

[FR Doc. 2017–28396 Filed 12–28–17; 4:15 pm] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

[NRC–2017–0238] 

Biweekly Notice; Applications and 

Amendments to Facility Operating 

Licenses and Combined Licenses 

Involving No Significant Hazards 

Considerations 

AGENCY: Nuclear Regulatory 

Commission. 

ACTION: Biweekly notice. 

SUMMARY: Pursuant to Section 189a. (2) 

of the Atomic Energy Act of 1954, as 

amended (the Act), the U.S. Nuclear 

Regulatory Commission (NRC) is 

publishing this regular biweekly notice. 

The Act requires the Commission to 

publish notice of any amendments 

issued, or proposed to be issued, and 

grants the Commission the authority to 

issue and make immediately effective 

any amendment to an operating license 

or combined license, as applicable, 

upon a determination by the 

Commission that such amendment 

involves no significant hazards 

consideration, notwithstanding the 

pendency before the Commission of a 

request for a hearing from any person. 

This biweekly notice includes all 

notices of amendments issued, or 

proposed to be issued, from December 5, 

2017, to December 18, 2017. The last 

biweekly notice was published on 

December 19, 2017. 

DATES: Comments must be filed by 

February 1, 2018. A request for a 

hearing must be filed by March 5, 2018. 

ADDRESSES: You may submit comments 

by any of the following methods (unless 

this document describes a different 

method for submitting comments on a 

specific subject): 

• Federal Rulemaking Website: Go to 

http://www.regulations.gov and search 

for Docket ID NRC–2017–0238. Address 

questions about NRC dockets to Carol 

Gallagher; telephone: 301–415–3463; 

email: Carol.Gallagher@nrc.gov. For 

technical questions, contact the 

individual listed in the FOR FURTHER

INFORMATION CONTACT section of this 

document. 

• Mail comments to: May Ma, Office 

of Administration, Mail Stop: OWFN–2– 

A13, U.S. Nuclear Regulatory 

Commission, Washington, DC 20555– 

0001. 

For additional direction on obtaining 

information and submitting comments, 

see ‘‘Obtaining Information and 

Submitting Comments’’ in the 

SUPPLEMENTARY INFORMATION section of 

this document. 

FOR FURTHER INFORMATION CONTACT: 

Lynn Ronewicz, Office of Nuclear 

Reactor Regulation, U.S. Nuclear 

Regulatory Commission, Washington DC 

20555–0001; telephone: 301–415–1927, 

email: Lynn.Ronewicz@nrc.gov. 

SUPPLEMENTARY INFORMATION: 

I. Obtaining Information and 

Submitting Comments 

A. Obtaining Information 

Please refer to Docket ID NRC–2017– 

0238, facility name, unit number(s), 

plant docket number, application date, 

and subject when contacting the NRC 

about the availability of information for 

this action. You may obtain publiclyavailable information related to this 

action by any of the following methods: 

• Federal Rulemaking Website: Go to 

http://www.regulations.gov and search 

for Docket ID NRC–2017–0238. 

• NRC’s Agencywide Documents 

Access and Management System 

(ADAMS): You may obtain publiclyavailable documents online in the 

ADAMS Public Documents collection at 

http://www.nrc.gov/reading-rm/ 

adams.html. To begin the search, select 

‘‘ADAMS Public Documents’’ and then 

select ‘‘Begin Web-based ADAMS 

Search.’’ For problems with ADAMS, 

please contact the NRC’s Public 

Document Room (PDR) reference staff at 

1–800–397–4209, 301–415–4737, or by 

email to pdr.resource@nrc.gov. The 

ADAMS accession number for each 

document referenced (if it is available in 

ADAMS) is provided the first time that 

it is mentioned in this document. 

• NRC’s PDR: You may examine and 

purchase copies of public documents at 

the NRC’s PDR, Room O1–F21, One 

White Flint North, 11555 Rockville 

Pike, Rockville, Maryland 20852. 

B. Submitting Comments 

Please include Docket ID NRC–2017– 

0238, facility name, unit number(s), 

plant docket number, application date, 

and subject in your comment 

submission. 

The NRC cautions you not to include 

identifying or contact information that 

you do not want to be publicly 

disclosed in your comment submission. 

The NRC will post all comment 

submissions at http://

www.regulations.gov as well as enter the 

comment submissions into ADAMS. 

The NRC does not routinely edit 

comment submissions to remove 

identifying or contact information. 

If you are requesting or aggregating 

comments from other persons for 

submission to the NRC, then you should 

inform those persons not to include 

identifying or contact information that 

they do not want to be publicly 

disclosed in their comment submission. 

Your request should state that the NRC 

does not routinely edit comment 

submissions to remove such information 

before making the comment 

submissions available to the public or 

entering the comment into ADAMS. 

II. Notice of Consideration of Issuance 

of Amendments to Facility Operating 

Licenses and Combined Licenses and 

Proposed No Significant Hazards 

Consideration Determination 

The Commission has made a 

proposed determination that the 

following amendment requests involve 

no significant hazards consideration. 

Under the Commission’s regulations in 

§ 50.92 of title 10 of the Code of Federal 

Regulations (10 CFR), this means that 

operation of the facility in accordance 

with the proposed amendment would 

not (1) involve a significant increase in 

the probability or consequences of an 

accident previously evaluated, or (2) 

create the possibility of a new or 

different kind of accident from any 

accident previously evaluated; or (3) 

involve a significant reduction in a 

margin of safety. The basis for this 

proposed determination for each 

amendment request is shown below. 

The Commission is seeking public 

comments on this proposed 

determination. Any comments received 

within 30 days after the date of 

publication of this notice will be 


daltland on DSKBBV9HB2PROD with NOTICES